Expertise in
14
conditions

Dr. Michael F. Vaezi

Gastroenterology
Office
1301 Medical Center Dr Ste 1660, 
Nashville, TN 
Accepting New Patients
Offers Telehealth
Expertise in
14
conditions
Office
1301 Medical Center Dr Ste 1660, 
Nashville, TN 

Overview

Michael Vaezi is a Gastroenterologist practicing medicine in Nashville, Tennessee.

Dr. Vaezi is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Gastroesophageal Reflux Disease (GERD), Esophagitis, Achalasia, Heartburn, and Endoscopy.

He is actively involved in clinical research, co-authoring 170 peer reviewed articles and participating in 11 clinical trials. Dr. Vaezi is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in TN

Hospital Affiliations

Williamson Medical Center
Vanderbilt University Medical Center

Languages Spoken

English
Farsi
Turkish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Office
1301 Medical Center Dr Ste 1660, Nashville, TN 37232

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Gastroesophageal Reflux Disease (GERD)
A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Gastroesophageal Reflux Disease (GERD)
Enrollment Status: Terminated
Publish Date: July 22, 2026
Intervention Type: Procedure, Device
Study Phase: Not Applicable
Mechanisms of Weight Loss in Patients Diagnosed With Achalasia: A Prospective Observational Study
Mechanisms of Weight Loss in Patients Diagnosed With Achalasia: A Prospective Observational Study
Enrollment Status: Completed
Publish Date: May 27, 2026
Intervention Type: Procedure
A Phase 3, Multicenter, Open-label Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Open-label Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Enrollment Status: Terminated
Publish Date: February 19, 2025
Intervention Type: Drug
Study Drug: Budesonide oral suspension
Study Phase: Phase 3
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
Enrollment Status: Completed
Publish Date: January 19, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
Development of an Esophageal Monitoring Device for the Assessment of Esophageal Epithelium Integrity With Mucosal Impedance
Development of an Esophageal Monitoring Device for the Assessment of Esophageal Epithelium Integrity With Mucosal Impedance
Enrollment Status: Completed
Publish Date: August 03, 2021
Intervention Type: Procedure
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Prospective, Observational Study of the PPI Non-responder
A Prospective, Observational Study of the PPI Non-responder
Enrollment Status: Withdrawn
Publish Date: April 02, 2019
Intervention Type: Diagnostic test
DUAL BRAVO PH MONITORING: A Feasibility Trial
DUAL BRAVO PH MONITORING: A Feasibility Trial
Enrollment Status: Completed
Publish Date: April 04, 2017
Intervention Type: Procedure, Device, Other
Study Phase: Not Applicable
View 9 Less Clinical Trials

170 Total Publications

Point-of-Care Esophageal Mucosal Impedance Testing for Diagnosing GERD and EoE.
Point-of-Care Esophageal Mucosal Impedance Testing for Diagnosing GERD and EoE.
Journal: Gastroenterology & hepatology
Published: July 02, 2026
Similar Doctors
Expertise in
11
conditions
Dr. David M. Schwartz
Gastroenterology
Expertise in
11
conditions
Dr. David M. Schwartz
Gastroenterology
Referral may be required

Office

1301 Medical Center Dr Ste 1660, 
Nashville, TN 
 (0.1 miles away)
615-322-0128
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Schwartz is a Gastroenterologist practicing medicine in Nashville, Tennessee. Dr. Schwartz is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Crohn's Disease, Pulmonary Fibrosis, Viral Gastroenteritis, Endoscopy, and Colonoscopy. Dr. Schwartz is currently accepting new patients.

Expertise in
18
conditions
Dr. Patrick S. Yachimski
Gastroenterology
Expertise in
18
conditions
Dr. Patrick S. Yachimski
Gastroenterology
Referral may be required

Office

1301 Medical Center Dr Ste 1660, 
Nashville, TN 
 (0.1 miles away)
615-322-0128
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Patrick Yachimski is a Gastroenterologist practicing medicine in Nashville, Tennessee. Dr. Yachimski is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Barrett Esophagus, Pancreatic Pseudocyst, Neuroma Biliary Tract, Endoscopy, and Pancreatectomy. Dr. Yachimski is currently accepting new patients.

Expertise in
7
conditions
Dr. Cathy H. Eng
Gastroenterology
Expertise in
7
conditions
Dr. Cathy H. Eng
Gastroenterology
Referral may be required

Vanderbilt-Ingram Cancer Center

2220 Pierce Ave, 
Nashville, TN 
 (0.1 miles away)
615-322-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Cathy Eng is a Gastroenterologist practicing medicine in Nashville, Tennessee. Dr. Eng is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Squamous Cell Carcinoma of the Anal Canal (SCAC), Colorectal Cancer, Appendix Cancer, Hepato-Pancreato-Biliary Surgery, and Hepatectomy. Dr. Eng is currently accepting new patients.

Frequently Asked Questions about Dr. Michael F. Vaezi

How do I make an appointment with Dr. Michael F. Vaezi?

You can book an appointment with Dr. Michael F. Vaezi by calling their office at 615-322-7427. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael F. Vaezi a top-rated expert for Gastroesophageal Reflux Disease (GERD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael F. Vaezi is classified as an Elite expert for Gastroesophageal Reflux Disease (GERD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael F. Vaezi specialize in?

While Dr. Michael F. Vaezi is a Gastroenterology, they have specific expertise in Gastroesophageal Reflux Disease (GERD), Esophagitis, and Achalasia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Michael F. Vaezi participate in research or clinical trials?

Yes. Dr. Michael F. Vaezi has published 170 articles and abstracts on conditions like Gastroesophageal Reflux Disease (GERD). You can view a list of Dr. Michael F. Vaezi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael F. Vaezi accept my insurance?

Dr. Michael F. Vaezi accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 615-322-7427 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Vaezi's expertise for a condition
ConditionClose
View All 18 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile